Jeffrey J Weiss1, Ioannis Konstantinidis, Anna Boueilh, Daniel S Fierer, Donald Gardenier, Mark G Barber, Tony Kang, Anna Kress, Katherine Ericson, Marlene C Lira, Marina P Yostos, Hillary R Bogner, Juan P Wisnivesky, Christina M Wyatt. 1. *Division of General Internal Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; †Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; ‡Department of Nephrology-Transplantation-Dialysis, Pellegrin Hospital, Bordeaux, France; §Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; ‖School of Medicine, University of Connecticut, Farmington, CT; ¶Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA; #Department of Internal Medicine, Columbia University Medical Center, New York-Presbyterian Hospital, New York, NY; **College of Medicine, SUNY Downstate Medical Center, Brooklyn, NY; ††Clinical Addiction Research and Education (CARE) Unit, General Internal Medicine, Medicine, Boston Medical Center, Boston, MA; ‡‡School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland; §§Department of Family Medicine and Community Health, Perelman School of Medicine, Philadelphia, PA; and ‖‖Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Abstract
BACKGROUND: Mortality in patients with HIV infection is increasingly due to comorbid medical conditions. Research on how adherence to medications for comorbidities relates to antiretroviral (ARV) medication adherence and how interrelations between illness perceptions and medication beliefs about HIV and comorbidities affect medication adherence is needed to inform adherence interventions. METHODS: HIV-infected adults with hypertension (HTN) (n = 151) or chronic kidney disease (CKD; n = 41) were recruited from ambulatory practices at an academic medical center. Illness perceptions and medication beliefs about HIV and HTN or CKD were assessed and adherence to one ARV medication and one medication for either HTN or CKD was electronically monitored for 10 weeks. RESULTS: Rates of taking, dosing, and timing adherence to ARV medication did not differ from adherence to medication for HTN or CKD, with the exception that patients were more adherent to the timing of their ARV (78%) than to the timing of their antihypertensive (68%; P = 0.01). Patients viewed HIV as better understood, more chronic, having more negative consequences, and eliciting more emotions, compared with HTN. Patients viewed ARVs as more necessary than medication for HTN or CKD. Having a realistic view of the efficacy of ARVs (r = -0.20; P < 0.05) and a high level of perceived HIV understanding (r = 0.21; P < 0.05) correlated with better ARV adherence. CONCLUSIONS: Patients with HIV showed similar rates of adherence to ARVs as to medications for comorbidities, despite perceiving HIV as more threatening and ARVs as more important. This can be used in adapting existing interventions for ARV adherence to encompass adherence to medications for comorbid conditions.
BACKGROUND: Mortality in patients with HIV infection is increasingly due to comorbid medical conditions. Research on how adherence to medications for comorbidities relates to antiretroviral (ARV) medication adherence and how interrelations between illness perceptions and medication beliefs about HIV and comorbidities affect medication adherence is needed to inform adherence interventions. METHODS:HIV-infected adults with hypertension (HTN) (n = 151) or chronic kidney disease (CKD; n = 41) were recruited from ambulatory practices at an academic medical center. Illness perceptions and medication beliefs about HIV and HTN or CKD were assessed and adherence to one ARV medication and one medication for either HTN or CKD was electronically monitored for 10 weeks. RESULTS: Rates of taking, dosing, and timing adherence to ARV medication did not differ from adherence to medication for HTN or CKD, with the exception that patients were more adherent to the timing of their ARV (78%) than to the timing of their antihypertensive (68%; P = 0.01). Patients viewed HIV as better understood, more chronic, having more negative consequences, and eliciting more emotions, compared with HTN. Patients viewed ARVs as more necessary than medication for HTN or CKD. Having a realistic view of the efficacy of ARVs (r = -0.20; P < 0.05) and a high level of perceived HIV understanding (r = 0.21; P < 0.05) correlated with better ARV adherence. CONCLUSIONS:Patients with HIV showed similar rates of adherence to ARVs as to medications for comorbidities, despite perceiving HIV as more threatening and ARVs as more important. This can be used in adapting existing interventions for ARV adherence to encompass adherence to medications for comorbid conditions.
Authors: Jonathan Shuter; Julie A Sarlo; Tina J Kanmaz; Richard A Rode; Barry S Zingman Journal: J Acquir Immune Defic Syndr Date: 2007-05-01 Impact factor: 3.731
Authors: Colette J Smith; Lene Ryom; Rainer Weber; Philippe Morlat; Christian Pradier; Peter Reiss; Justyna D Kowalska; Stephane de Wit; Matthew Law; Wafaa el Sadr; Ole Kirk; Nina Friis-Moller; Antonella d'Arminio Monforte; Andrew N Phillips; Caroline A Sabin; Jens D Lundgren Journal: Lancet Date: 2014-07-19 Impact factor: 79.321
Authors: Matthew S Freiberg; Chung-Chou H Chang; Lewis H Kuller; Melissa Skanderson; Elliott Lowy; Kevin L Kraemer; Adeel A Butt; Matthew Bidwell Goetz; David Leaf; Kris Ann Oursler; David Rimland; Maria Rodriguez Barradas; Sheldon Brown; Cynthia Gibert; Kathy McGinnis; Kristina Crothers; Jason Sico; Heidi Crane; Alberta Warner; Stephen Gottlieb; John Gottdiener; Russell P Tracy; Matthew Budoff; Courtney Watson; Kaku A Armah; Donna Doebler; Kendall Bryant; Amy C Justice Journal: JAMA Intern Med Date: 2013-04-22 Impact factor: 21.873
Authors: Richard A Hansen; Mimi M Kim; Liping Song; Wanzhu Tu; Jingwei Wu; Michael D Murray Journal: Ann Pharmacother Date: 2009-03-03 Impact factor: 3.154
Authors: Christina M Wyatt; Jonathan A Winston; Carlos D Malvestutto; Dawn A Fishbein; Irina Barash; Alan J Cohen; Mary E Klotman; Paul E Klotman Journal: AIDS Date: 2007-10-01 Impact factor: 4.177
Authors: Joseph L Goulet; Shawn L Fultz; David Rimland; Adeel Butt; Cynthia Gibert; Maria Rodriguez-Barradas; Kendall Bryant; Amy C Justice Journal: Clin Infect Dis Date: 2007-12-15 Impact factor: 9.079
Authors: Preeti Manavalan; Linda Minja; Lisa Wanda; Julian T Hertz; Nathan M Thielman; Nwora Lance Okeke; Blandina T Mmbaga; Melissa H Watt Journal: PLoS One Date: 2020-12-03 Impact factor: 3.240
Authors: Louise Foley; James Larkin; Richard Lombard-Vance; Andrew W Murphy; Lisa Hynes; Emer Galvin; Gerard J Molloy Journal: BMJ Open Date: 2021-09-02 Impact factor: 3.006
Authors: Charles Muiruri; Isabelle P Sico; Julie Schexnayder; Allison R Webel; Nwora Lance Okeke; Christopher T Longenecker; Juan Marcos Gonzalez; Kelley A Jones; Sarah E Gonzales; Hayden B Bosworth Journal: Patient Prefer Adherence Date: 2020-06-16 Impact factor: 2.711
Authors: Risa M Hoffman; Florence Chibwana; Daniel Kahn; Ben Allan Banda; Linna Phiri; Mayamiko Chimombo; Chiulemu Kussen; Hitler Sigauke; Agnes Moses; Joep J van Oosterhout; Sam Phiri; Jesse W Currier; Judith S Currier; Corrina Moucheraud Journal: Glob Heart Date: 2021-12-06